Feasibility and efficacy of Lenalidomide maintenance after salvage immuno-chemotherapy induction in relapsed or refractory mantle cell lymphoma - a phase II study of the European MCL Network.
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2012
At a glance
- Drugs Lenalidomide (Primary)
- Indications Mantle-cell lymphoma
- Focus Adverse reactions
- 28 Jul 2011 New trial record